Fourier Transform Infrared Spectroscopy As a Cancer Screening and Diagnostic Tool: A Review and Prospects

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Jan 8

PMID 31906324

Citations 49

Authors

Kar-Yan Su

Wai-Leng Lee

Affiliations

Soon will be listed here.

Abstract

Infrared spectroscopy has long been used to characterize chemical compounds, but the applicability of this technique to the analysis of biological materials containing highly complex chemical components is arguable. However, recent advances in the development of infrared spectroscopy have significantly enhanced the capacity of this technique in analyzing various types of biological specimens. Consequently, there is an increased number of studies investigating the application of infrared spectroscopy in screening and diagnosis of various diseases. The lack of highly sensitive and specific methods for early detection of cancer has warranted the search for novel approaches. Being more simple, rapid, accurate, inexpensive, non-destructive and suitable for automation compared to existing screening, diagnosis, management and monitoring methods, Fourier transform infrared spectroscopy can potentially improve clinical decision-making and patient outcomes by detecting biochemical changes in cancer patients at the molecular level. Besides the commonly analyzed blood and tissue samples, extracellular vesicle-based method has been gaining popularity as a non-invasive approach. Therefore, infrared spectroscopic analysis of extracellular vesicles could be a useful technique in the future for biomedical applications. In this review, we discuss the potential clinical applications of Fourier transform infrared spectroscopic analysis using various types of biological materials for cancer. Additionally, the rationale and advantages of using extracellular vesicles in the spectroscopic analysis for cancer diagnostics are discussed. Furthermore, we highlight the challenges and future directions of clinical translation of the technique for cancer.

Citing Articles

A Scoping Review of Infrared Spectroscopy and Machine Learning Methods for Head and Neck Precancer and Cancer Diagnosis and Prognosis.

Alajaji S, Sabzian R, Wang Y, Sultan A, Wang R Cancers (Basel). 2025; 17(5).

PMID: 40075644 PMC: 11899414. DOI: 10.3390/cancers17050796.

Automatic Characterization of High-Performance MEMS-Based IR Sensors.

Benson M, Parker R, Gulseren M, Gomez-Diaz J IEEE Access. 2025; 12:190120-190133.

PMID: 39917637 PMC: 11801411. DOI: 10.1109/access.2024.3517543.

Application of Fourier transform infrared spectroscopy to exhaled breath analysis for detecting helicobacter pylori infection.

Qiu M, Liao F, Tan Y, Zhang J, Zheng C, Wang H Sci Rep. 2024; 14(1):31542.

PMID: 39732993 PMC: 11682097. DOI: 10.1038/s41598-024-83360-0.

Advancing frontline early pancreatic cancer detection using within-class feature extraction in FTIR spectroscopy.

Tang Z, Duckworth E, Mora B, Al-Sarireh B, Mortimer M, Roy D Sci Rep. 2024; 14(1):28940.

PMID: 39578495 PMC: 11584613. DOI: 10.1038/s41598-024-79153-0.

Infrared spectroscopy as a new approach for early fabry disease screening: a pilot study.

Barretto C, Nascimento M, Brun B, da Silva T, Dias P, Silva C Orphanet J Rare Dis. 2024; 19(1):373.

PMID: 39390597 PMC: 11466028. DOI: 10.1186/s13023-024-03380-x.

References

Kyriakidou M, Anastassopoulou J, Tsakiris A, Koui M, Theophanides T . FT-IR Spectroscopy Study in Early Diagnosis of Skin Cancer. In Vivo. 2017; 31(6):1131-1137. PMC: 5756641. DOI: 10.21873/invivo.11179. View

Walsh M, Singh M, Stringfellow H, Pollock H, Hammiche A, Grude O . FTIR Microspectroscopy Coupled with Two-Class Discrimination Segregates Markers Responsible for Inter- and Intra-Category Variance in Exfoliative Cervical Cytology. Biomark Insights. 2008; 3:179-189. PMC: 2493409. DOI: 10.4137/bmi.s592. View

GLEASON D . Classification of prostatic carcinomas. Cancer Chemother Rep. 1966; 50(3):125-8. View

Franca C, Izar M, do Amaral J, Tegani D, Fonseca F . Microparticles as potential biomarkers of cardiovascular disease. Arq Bras Cardiol. 2015; 104(2):169-74. PMC: 4375661. DOI: 10.5935/abc.20140210. View

Henry N, Hayes D . Cancer biomarkers. Mol Oncol. 2012; 6(2):140-6. PMC: 5528374. DOI: 10.1016/j.molonc.2012.01.010. View

Mause S, Weber C . Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010; 107(9):1047-57. DOI: 10.1161/CIRCRESAHA.110.226456. View

Zelig U, Mordechai S, Shubinsky G, Sahu R, Huleihel M, Leibovitz E . Pre-screening and follow-up of childhood acute leukemia using biochemical infrared analysis of peripheral blood mononuclear cells. Biochim Biophys Acta. 2011; 1810(9):827-35. DOI: 10.1016/j.bbagen.2011.06.010. View

Caine S, Heraud P, Tobin M, McNaughton D, Bernard C . The application of Fourier transform infrared microspectroscopy for the study of diseased central nervous system tissue. Neuroimage. 2011; 59(4):3624-40. DOI: 10.1016/j.neuroimage.2011.11.033. View

Frankland J, Brodie H, Cooke D, Foster C, Foster R, Gage H . Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme. BMC Cancer. 2019; 19(1):368. PMC: 6480799. DOI: 10.1186/s12885-019-5561-0. View

10.

Das S, Halushka M . Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol. 2015; 24(4):199-206. DOI: 10.1016/j.carpath.2015.04.007. View

11.

Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong D . Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One. 2010; 5(1):e8577. PMC: 2797607. DOI: 10.1371/journal.pone.0008577. View

12.

Baratloo A, Hosseini M, Negida A, El Ashal G . Part 1: Simple Definition and Calculation of Accuracy, Sensitivity and Specificity. Emerg (Tehran). 2015; 3(2):48-9. PMC: 4614595. View

13.

Arruebo M, Vilaboa N, Saez-Gutierrez B, Lambea J, Tres A, Valladares M . Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 2013; 3(3):3279-330. PMC: 3759197. DOI: 10.3390/cancers3033279. View

14.

Holmstrom B, Johansson M, Bergh A, Stenman U, Hallmans G, Stattin P . Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ. 2009; 339:b3537. PMC: 2751815. DOI: 10.1136/bmj.b3537. View

15.

Ollesch J, Heinze M, Heise H, Behrens T, Bruning T, Gerwert K . It's in your blood: spectral biomarker candidates for urinary bladder cancer from automated FTIR spectroscopy. J Biophotonics. 2014; 7(3-4):210-21. DOI: 10.1002/jbio.201300163. View

16.

Lima K, Gajjar K, Martin-Hirsch P, Martin F . Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: ATR-FTIR spectroscopy coupled with variable selection methods. Biotechnol Prog. 2015; 31(3):832-9. DOI: 10.1002/btpr.2084. View

17.

Kwast A, Drossaert C, Siesling S . Breast cancer follow-up: from the perspective of health professionals and patients. Eur J Cancer Care (Engl). 2013; 22(6):754-64. DOI: 10.1111/ecc.12094. View

18.

Poste G . Bring on the biomarkers. Nature. 2011; 469(7329):156-7. DOI: 10.1038/469156a. View

19.

Shah A . Postoperative pathologic assessment of surgical margins in oral cancer: A contemporary review. J Oral Maxillofac Pathol. 2018; 22(1):78-85. PMC: 5917547. DOI: 10.4103/jomfp.JOMFP_185_16. View

20.

Loo P, Thomas S, Nicolson M, Fyfe M, Kerr K . Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol. 2010; 5(4):442-7. DOI: 10.1097/JTO.0b013e3181d40fac. View